Wells Fargo Maintains Overweight on Amrize, Raises Price Target to $58

Benzinga · 10/30 14:58
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $57 to $58.